Selectis Health, Inc. (GBCS)
USD 2.0
(-6.98%)
USD 2.0
(-6.98%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 5.4 Million USD | -49.91% |
| 2022 | 7.46 Million USD | 18.56% |
| 2021 | 6.29 Million USD | -16.51% |
| 2020 | 7.54 Million USD | 80.93% |
| 2019 | 4.16 Million USD | 47.21% |
| 2018 | 2.83 Million USD | 4.69% |
| 2017 | 2.7 Million USD | 236.0% |
| 2016 | 805.23 Thousand USD | -62.35% |
| 2015 | 2.13 Million USD | 45.27% |
| 2014 | 1.47 Million USD | 297.55% |
| 2013 | 370.37 Thousand USD | 1225.28% |
| 2012 | -32.91 Thousand USD | -202.02% |
| 2011 | 32.26 Thousand USD | -87.75% |
| 2010 | 263.42 Thousand USD | -42.7% |
| 2009 | 459.72 Thousand USD | 1.39% |
| 2008 | 453.41 Thousand USD | -10.53% |
| 2007 | 506.76 Thousand USD | -27.93% |
| 2006 | 703.17 Thousand USD | -25.68% |
| 2005 | 946.16 Thousand USD | 55.83% |
| 2004 | 607.18 Thousand USD | 39.09% |
| 2003 | 436.53 Thousand USD | 57.03% |
| 2002 | 278 Thousand USD | -92.6% |
| 2001 | 3.75 Million USD | -28.25% |
| 2000 | 5.23 Million USD | -24.15% |
| 1999 | 6.9 Million USD | -28.09% |
| 1998 | 9.6 Million USD | 4.02% |
| 1997 | 9.23 Million USD | 23.5% |
| 1996 | 7.47 Million USD | 2.42% |
| 1995 | 7.3 Million USD | 290.37% |
| 1994 | 1.87 Million USD | 79.81% |
| 1993 | 1.04 Million USD | 10.64% |
| 1992 | 940 Thousand USD | -23.58% |
| 1991 | 1.23 Million USD | -0.81% |
| 1990 | 1.24 Million USD | 27.84% |
| 1989 | 970 Thousand USD | -15.65% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 1.56 Million USD | 52.22% |
| 2024 Q2 | 1.75 Million USD | 38.32% |
| 2023 Q1 | 276.46 Thousand USD | -84.22% |
| 2023 Q3 | 1.34 Million USD | 89.17% |
| 2023 Q2 | 712.14 Thousand USD | 157.59% |
| 2023 FY | 3.74 Million USD | -49.91% |
| 2023 Q4 | 1.02 Million USD | -23.56% |
| 2022 Q1 | 2.56 Million USD | 1514.93% |
| 2022 Q2 | 2.42 Million USD | -5.16% |
| 2022 FY | 7.46 Million USD | 18.56% |
| 2022 Q4 | 1.75 Million USD | -15.21% |
| 2022 Q3 | 2.06 Million USD | -14.89% |
| 2021 Q3 | 2.9 Million USD | 114.12% |
| 2021 Q1 | 2.21 Million USD | 121.82% |
| 2021 Q4 | -180.93 Thousand USD | -106.23% |
| 2021 FY | 6.29 Million USD | -16.51% |
| 2021 Q2 | 1.35 Million USD | -38.83% |
| 2020 Q2 | 2.47 Million USD | 62.93% |
| 2020 Q3 | 2.54 Million USD | 2.91% |
| 2020 Q4 | 999.95 Thousand USD | -60.76% |
| 2020 Q1 | 1.51 Million USD | 71.16% |
| 2020 FY | 7.54 Million USD | 80.93% |
| 2019 Q2 | 1.07 Million USD | 15.63% |
| 2019 Q1 | 925.89 Thousand USD | 36.27% |
| 2019 Q3 | 1.28 Million USD | 20.05% |
| 2019 Q4 | 887.99 Thousand USD | -30.91% |
| 2019 FY | 4.16 Million USD | 47.21% |
| 2018 Q2 | 754.86 Thousand USD | 3.23% |
| 2018 Q1 | 731.24 Thousand USD | -5.94% |
| 2018 Q4 | 679.45 Thousand USD | 1.89% |
| 2018 FY | 2.83 Million USD | 4.69% |
| 2018 Q3 | 666.87 Thousand USD | -11.66% |
| 2017 Q3 | 706.01 Thousand USD | 647.29% |
| 2017 Q4 | 777.39 Thousand USD | 10.11% |
| 2017 Q1 | 572.71 Thousand USD | 241.88% |
| 2017 Q2 | -129 Thousand USD | -122.52% |
| 2017 FY | 2.7 Million USD | 236.0% |
| 2016 FY | 805.23 Thousand USD | -62.35% |
| 2016 Q3 | 807.26 Thousand USD | 603.09% |
| 2016 Q4 | 167.51 Thousand USD | -79.25% |
| 2016 Q1 | 643.44 Thousand USD | 933.25% |
| 2016 Q2 | -160.46 Thousand USD | -124.94% |
| 2015 FY | 2.13 Million USD | 45.27% |
| 2015 Q4 | 62.27 Thousand USD | -93.61% |
| 2015 Q2 | 1.14 Million USD | 11.39% |
| 2015 Q3 | 974.42 Thousand USD | -14.68% |
| 2015 Q1 | 1.02 Million USD | 116.4% |
| 2014 FY | 1.47 Million USD | 297.55% |
| 2014 Q4 | 473.78 Thousand USD | 4.45% |
| 2014 Q1 | 233.27 Thousand USD | 145.46% |
| 2014 Q2 | 311.75 Thousand USD | 33.64% |
| 2014 Q3 | 453.6 Thousand USD | 45.5% |
| 2013 Q3 | -851.12 Thousand USD | 43.49% |
| 2013 Q2 | -1.5 Million USD | -2106.6% |
| 2013 Q4 | -513.12 Thousand USD | 39.71% |
| 2013 Q1 | -68.25 Thousand USD | 22.33% |
| 2013 FY | 370.37 Thousand USD | 1225.28% |
| 2012 Q3 | 46.6 Thousand USD | -44.55% |
| 2012 FY | -32.91 Thousand USD | -202.02% |
| 2012 Q4 | -87.87 Thousand USD | -288.55% |
| 2012 Q2 | 84.05 Thousand USD | 481.53% |
| 2012 Q1 | -22.03 Thousand USD | 81.18% |
| 2011 Q4 | -117.08 Thousand USD | -628.72% |
| 2011 FY | 32.26 Thousand USD | -87.75% |
| 2011 Q1 | -7839.00 USD | -87.94% |
| 2011 Q2 | 26.4 Thousand USD | 436.82% |
| 2011 Q3 | 22.14 Thousand USD | -16.13% |
| 2010 Q4 | -4171.00 USD | -123.34% |
| 2010 Q1 | 140.86 Thousand USD | 238.7% |
| 2010 FY | 263.42 Thousand USD | -42.7% |
| 2010 Q3 | 17.86 Thousand USD | -63.14% |
| 2010 Q2 | 48.47 Thousand USD | -65.59% |
| 2009 Q1 | 69.5 Thousand USD | 361.25% |
| 2009 Q4 | -101.56 Thousand USD | -146.48% |
| 2009 Q3 | 218.5 Thousand USD | -23.09% |
| 2009 FY | 459.72 Thousand USD | 1.39% |
| 2009 Q2 | 284.12 Thousand USD | 308.79% |
| 2008 Q3 | 132.7 Thousand USD | -28.21% |
| 2008 Q4 | -26.6 Thousand USD | -120.05% |
| 2008 FY | 453.41 Thousand USD | -10.53% |
| 2008 Q2 | 184.85 Thousand USD | 11324.66% |
| 2008 Q1 | 1618.00 USD | -98.74% |
| 2007 Q4 | 128.91 Thousand USD | -6.6% |
| 2007 Q3 | 138.02 Thousand USD | 53.68% |
| 2007 Q1 | 103.63 Thousand USD | 52.12% |
| 2007 Q2 | 89.81 Thousand USD | -13.34% |
| 2007 FY | 506.76 Thousand USD | -27.93% |
| 2006 FY | 703.17 Thousand USD | -25.68% |
| 2006 Q2 | 171.88 Thousand USD | 49.96% |
| 2006 Q3 | 245.17 Thousand USD | 42.64% |
| 2006 Q4 | 68.13 Thousand USD | -72.21% |
| 2006 Q1 | 114.62 Thousand USD | -13.98% |
| 2005 FY | 946.16 Thousand USD | 55.83% |
| 2005 Q4 | 133.24 Thousand USD | -52.99% |
| 2005 Q3 | 283.42 Thousand USD | 55.39% |
| 2005 Q2 | 182.39 Thousand USD | -24.47% |
| 2005 Q1 | 241.48 Thousand USD | -5.85% |
| 2004 Q3 | 265.78 Thousand USD | 67.57% |
| 2004 Q4 | 256.5 Thousand USD | -3.49% |
| 2004 FY | 607.18 Thousand USD | 39.09% |
| 2004 Q1 | 209.12 Thousand USD | 144.84% |
| 2004 Q2 | 158.6 Thousand USD | -24.16% |
| 2003 Q2 | 120.08 Thousand USD | 19.1% |
| 2003 Q3 | 154.04 Thousand USD | 28.29% |
| 2003 Q4 | 85.41 Thousand USD | -44.55% |
| 2003 FY | 436.53 Thousand USD | 57.03% |
| 2003 Q1 | 100.82 Thousand USD | 62.13% |
| 2002 Q2 | -2.54 Million USD | -373.79% |
| 2002 FY | 278 Thousand USD | -92.6% |
| 2002 Q3 | 153.44 Thousand USD | 106.02% |
| 2002 Q4 | 62.18 Thousand USD | -59.47% |
| 2002 Q1 | 931 Thousand USD | 1.75% |
| 2001 Q2 | 860 Thousand USD | -9.47% |
| 2001 FY | 3.75 Million USD | -28.25% |
| 2001 Q1 | 950 Thousand USD | 3.94% |
| 2001 Q4 | 915 Thousand USD | -6.63% |
| 2001 Q3 | 980 Thousand USD | 13.95% |
| 2000 FY | 5.23 Million USD | -24.15% |
| 2000 Q1 | 1.38 Million USD | -10.08% |
| 2000 Q2 | 496 Thousand USD | -64.14% |
| 2000 Q3 | 1.03 Million USD | 108.67% |
| 2000 Q4 | 914 Thousand USD | -11.69% |
| 1999 FY | 6.9 Million USD | -28.09% |
| 1999 Q1 | 2.05 Million USD | 15.17% |
| 1999 Q2 | 1.25 Million USD | -39.02% |
| 1999 Q3 | 1.82 Million USD | 45.6% |
| 1999 Q4 | 1.53 Million USD | -15.49% |
| 1998 Q3 | 1.83 Million USD | 10.24% |
| 1998 Q4 | 1.78 Million USD | -2.73% |
| 1998 FY | 9.6 Million USD | 4.02% |
| 1998 Q1 | 2.74 Million USD | -1.44% |
| 1998 Q2 | 1.66 Million USD | -39.42% |
| 1997 Q2 | 1.93 Million USD | -34.8% |
| 1997 FY | 9.23 Million USD | 23.5% |
| 1997 Q3 | 2.35 Million USD | 21.76% |
| 1997 Q1 | 2.96 Million USD | 17.46% |
| 1997 Q4 | 2.78 Million USD | 18.3% |
| 1996 FY | 7.47 Million USD | 2.42% |
| 1996 Q4 | 2.52 Million USD | 37.7% |
| 1996 Q3 | 1.83 Million USD | 20.39% |
| 1996 Q2 | 1.52 Million USD | -31.84% |
| 1996 Q1 | 2.23 Million USD | 10.4% |
| 1995 FY | 7.3 Million USD | 290.37% |
| 1995 Q4 | 2.02 Million USD | 18.13% |
| 1995 Q3 | 1.71 Million USD | -10.47% |
| 1995 Q2 | 1.91 Million USD | -13.18% |
| 1995 Q1 | 2.2 Million USD | 34.15% |
| 1994 Q4 | 1.64 Million USD | 5.13% |
| 1994 Q1 | 530 Thousand USD | 120.83% |
| 1994 Q2 | 1.1 Million USD | 107.55% |
| 1994 Q3 | 1.56 Million USD | 41.82% |
| 1994 FY | 1.87 Million USD | 79.81% |
| 1993 Q2 | - USD | 0.0% |
| 1993 Q1 | - USD | 0.0% |
| 1993 FY | 1.04 Million USD | 10.64% |
| 1993 Q4 | 240 Thousand USD | 0.0% |
| 1993 Q3 | - USD | 0.0% |
| 1992 FY | 940 Thousand USD | -23.58% |
| 1992 Q1 | 260 Thousand USD | -62.32% |
| 1992 Q2 | -120 Thousand USD | -146.15% |
| 1992 Q4 | - USD | 0.0% |
| 1992 Q3 | - USD | 100.0% |
| 1991 FY | 1.23 Million USD | -0.81% |
| 1991 Q1 | 400 Thousand USD | -51.81% |
| 1991 Q3 | 110 Thousand USD | 168.75% |
| 1991 Q2 | -160 Thousand USD | -140.0% |
| 1991 Q4 | 690 Thousand USD | 527.27% |
| 1990 FY | 1.24 Million USD | 27.84% |
| 1990 Q4 | 830 Thousand USD | 453.33% |
| 1990 Q2 | -170 Thousand USD | -156.67% |
| 1990 Q1 | 300 Thousand USD | 0.0% |
| 1990 Q3 | 150 Thousand USD | 188.24% |
| 1989 FY | 970 Thousand USD | -15.65% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| The Amacore Group, Inc. | 9.39 Million USD | 42.463% |
| Arem Pacific Corporation | 239.16 Thousand USD | -2160.863% |
| Assisted 4 Living, Inc. | 712.32 Thousand USD | -659.082% |
| BioCorRx Inc. | 53.17 Thousand USD | -10068.74% |
| Bionik Laboratories Corp. | 989.87 Thousand USD | -446.242% |
| Banyan Corp. | 5 Million USD | -8.063% |
| Clearday, Inc. | -6.84 Million USD | 178.941% |
| Dental Patient Care America, Inc. | 3.24 Million USD | -66.665% |
| Quantum Medical Transport, Inc. | 1097.61 USD | -492527.254% |
| Empower Clinics Inc. | 1.96 Million USD | -174.749% |
| First Choice Healthcare Solutions, Inc. | -12.19 Thousand USD | 44435.241% |
| Ethema Health Corporation | 4.66 Million USD | -15.813% |
| HealthLynked Corp. | 2.34 Million USD | -130.212% |
| HQDA Elderly Life Network Corp. | - USD | -Infinity% |
| Healthcare Solutions Management Group, Inc. | 6.78 Million USD | 20.303% |
| JRSIS Health Care Corporation | 483.05 Thousand USD | -1019.37% |
| Comjoyful International Company | - USD | -Infinity% |
| Medical Facilities Corporation | 143.69 Million USD | 96.237% |
| MedSmart Group Inc. | -19.03 Thousand USD | 28501.754% |
| North America Frac Sand, Inc. | 73.25 Thousand USD | -7281.137% |
| Nova Leap Health Corp. | 9.76 Million USD | 44.647% |
| Nexteligent Holdings, Inc. | 351.66 Thousand USD | -1437.587% |
| PAO Group, Inc. | - USD | -Infinity% |
| Primemd Inc. | 10.5 Million USD | 48.512% |
| Raffles Medical Group Ltd | 239.4 Million USD | 97.741% |
| Ryman Healthcare Limited | 260.65 Million USD | 97.926% |
| Stem Cell Authority, Ltd. | - USD | -Infinity% |
| SETO Holdings, Inc. | - USD | -Infinity% |
| Optima Medical Innovations Corp. | -1.21 Million USD | 546.405% |
| Mycotopia Therapies, Inc. | -61.21 Thousand USD | 8932.72% |
| U.S. NeuroSurgical Holdings, Inc. | -20 Thousand USD | 27135.63% |
| Veltex Corporation | 694.58 Thousand USD | -678.467% |
| World Financial Holding Group | - USD | -Infinity% |
| Xcelerate Inc. | 294.11 Thousand USD | -1738.427% |